Starch-Based Fast-Dissolving Oral Vaccine Dosage Form
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing oral vaccine delivery methods face challenges in effectively stimulating mucosal immunity due to degradation in the gastrointestinal tract and poor absorption of antigens, leading to inadequate immune responses, and there is a need for improved solid oral dosage forms that can induce immune responses as effectively as injectable vaccines while being easy to administer and manufacture.
Innovation Solution
A fast-dissolving oral solid vaccine dosage form comprising an immunogenic amount of an antigenic preparation, a starch as an immune response potentiating matrix forming agent, and optional additional matrix forming agents like mannitol and gelatin, which facilitates rapid antigen uptake in the oral cavity, avoiding gastrointestinal degradation and enhancing both humoral and cell-mediated immune responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional tablets are used for oral vaccine delivery, then manufacturing is simple, but antigen absorption is poor and immune response is inadequate
Solution Approach 1:
The patent changes the physical and chemical parameters of the dosage form by using freeze-drying to create a porous, fast-dissolving structure with specific surface area and porosity characteristics. This transforms the conventional dense tablet into a highly porous matrix that rapidly dissolves in oral fluids, exposing antigens to mucosal surfaces and significantly improving immune response effectiveness while maintaining manufacturing feasibility through established freeze-drying technology
Solution Approach 2:
The patent employs composite materials by combining the antigen with a porous matrix forming agent (such as gelatin, dextrin, or starch) and optionally with adjuvants and stabilizers. This composite structure provides both the mechanical integrity needed for handling and the rapid dissolution properties needed for effective mucosal delivery, resolving the contradiction between manufacturing simplicity and immune response effectiveness
2Ease of operation
If injectable vaccines are used, then immune response is effective, but administration is traumatic and inconvenient
Solution Approach 1:
The patent replaces the mechanical injection system with an oral delivery system that utilizes the natural physiology of the oral cavity. The fast-dissolving dosage form dissolves in oral fluids and delivers antigens directly to mucosal surfaces through passive dissolution and diffusion, eliminating the need for needles and injection equipment while maintaining immunogenicity by targeting the same mucosal-associated lymphoid tissues that injectable vaccines reach
Solution Approach 2:
The porous fast-dissolving matrix acts as an intermediary carrier that protects the antigen during oral administration and facilitates its transfer to mucosal surfaces. The matrix forming agent (gelatin, dextrin, starch) serves as a biocompatible intermediary that dissolves rapidly in oral fluids, releasing the antigen in a controlled manner directly at the absorption site, thereby achieving injectable-level effectiveness through an oral route
3Ease of operation
If oral vaccine is delivered through gastrointestinal tract, then administration is easy, but antigen degradation occurs and absorption is poor
Solution Approach 1:
The patent applies preliminary action by designing the dosage form to dissolve and release antigens in the oral cavity before the antigen enters the gastrointestinal tract. The fast-dissolving matrix releases antigens at the protected site of the oral mucosa, allowing absorption through mucosal surfaces before exposure to the harsh gastrointestinal environment with its degradative enzymes and acidic conditions, thereby preserving antigen integrity and enhancing absorption
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The starch-based formulation achieves improved immune responses by facilitating antigen uptake and absorption, inducing both systemic and mucosal immunity without the need for potent adjuvants, making it effective against a range of infectious agents and providing long-lasting protection.
Implementation Method 1
fast-dissolving oral solid vaccine dosage form comprising an immunogenic amount of an antigenic preparation, a starch as an immune response potentiating matrix forming agent
Implementation Method 2
facilitates rapid antigen uptake in the oral cavity
Implementation Method 3
FDDFs manufactured by the freeze-drying process such as the Zydis® dosage form
Data Source
Figure 1
Figure 2~3
Figure 4~5
AI summary
A fast-dissolving dosage form (FDDF) for the delivery of a vaccine is prepared using a formulation containing a starch, optionally, along with at least one additional matrix forming agent, preferably, a combination of gelatin and mannitol, wherein an immune response is induced in a patient in need thereof.